Molecular Clue May Treat Autism Spectrum Disorder

Topic: Autism Information
Author: Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Published: 2022/12/14 - Updated: 2023/01/03 - Peer-Reviewed: Yes
Contents: Summary - Definition - Introduction - Main Item - Related Topics

Synopsis: Researchers identify the cell-specific molecular network of autism spectrum disorder, thereby laying the foundation for treating ASD. Most autism spectrum disorder patients have behavioral disorders, sometimes accompanied by other developmental disabilities. The multi-omics integrated analysis technology developed through this study has advanced the pathological understanding of autism spectrum disorder and made it possible to discover an integrated network ranging from molecular-level cell differentiation induced by a specific autism gene to biometric information.

Introduction

Cntnap2-dependent molecular networks in autism spectrum disorder revealed through an integrative multi-omics analysis.

Professor Kim Min-sik's team of the Department of New Biology, DGIST (President: Kuk Yang), succeeded in identifying the cell-specific molecular network of Autism Spectrum Disorder. It is expected to lay the foundation for treating ASD.

Main Item

Autism Spectrum Disorder is known to occur from early childhood and is a neuro-developmental disorder characterized by continuous impairment of social communication and interaction-related behaviors leading to limited ranges of behavioral patterns, interests, and activities, and repetitive behaviors.

Most autism spectrum disorder patients have behavioral disorders, sometimes accompanied by other developmental disabilities. Currently, since there is no accurate molecular diagnosis method, early diagnosis of autism spectrum disorder is made at a fairly late period, and there is no appropriate treatment.

The image depicts a human head silhouette with puzzle pieces missing in the brain area.
The image depicts a human head silhouette with jigsaw puzzle pieces missing in the brain area.

Professor Kim Min-sik's team utilized the Cntnap2 defect model, a spectral disorder mouse model established by Professor Lee Yong-Seok's team at Seoul National University College of Medicine to extract prefrontal cortex tissue and performed mass spectrometry-based integrated quantitative proteomic and metabolomic analysis. In addition, by comparing and analyzing this with previously reported big data of autism spectrum disorder patients, the team confirmed that problems occur in networks such as metabolism and synapses in excitable neurons.

Professor Kim Min-sik of the Department of New Biology said:

"The multi-omics integrated analysis technology developed through this study has advanced the pathological understanding of autism spectrum disorder and made it possible to discover an integrated network ranging from molecular-level cell differentiation induced by a specific autism gene to biometric information," and added, "We are trying to find the core network of autism spectrum disorder and discover treatment targets by conducting an integrated analysis of various models."

The results of this research were published in Molecular Psychiatry on October 17, 2022, and this research was carried out with support from the Brain Science Source Technology Development Project of the Ministry of Science and ICT.

Related Information

Attribution/Source(s):

This peer reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by Daegu Gyeongbuk Institute of Science and Technology (DGIST), and published on 2022/12/14 (Edit Update: 2023/01/03), the content may have been edited for style, clarity, or brevity. For further details or clarifications, Daegu Gyeongbuk Institute of Science and Technology (DGIST) can be contacted at dgist.ac.kr/en/. NOTE: Disabled World does not provide any warranties or endorsements related to this article.

Explore Related Topics

1 - - Phenomenological study on the lived experiences of autistic adults who were previously diagnosed with Borderline Personality Disorder (BPD).

2 - - Researchers found that knocking out the Astrotactin 2 gene leads to several hallmark behaviors of autism.

3 - - Comprehensive list of studies and research articles on the causes and treatments of autism spectrum disorders.

4 - - Researchers unveil the link between cord blood fatty acid metabolites and autism spectrum disorder (ASD) symptoms in children.

5 - - New research highlights a therapeutic target that could make thinking easier for patients with Rett syndrome and other neurological disorders.

Complete List of Related Information

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Daegu Gyeongbuk Institute of Science and Technology (DGIST). (2022, December 14 - Last revised: 2023, January 3). Molecular Clue May Treat Autism Spectrum Disorder. Disabled World. Retrieved October 10, 2024 from www.disabled-world.com/health/neurology/autism/cntnap2.php

Permalink: <a href="https://www.disabled-world.com/health/neurology/autism/cntnap2.php">Molecular Clue May Treat Autism Spectrum Disorder</a>: Researchers identify the cell-specific molecular network of autism spectrum disorder, thereby laying the foundation for treating ASD.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.